Diagnosis of Parkinson’s Disease by A Metabolomics-Based Laboratory-Developed Test (LDT)
A laboratory-developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used in the same laboratory (i.e., an in-house test). In this study, a metabolomics-based LDT was developed. This test involves a blood plasma preparation, direct-infusion mass spectrometry ana...
Main Authors: | Petr G. Lokhov, Oxana P. Trifonova, Dmitry L. Maslov, Steven Lichtenberg, Elena E. Balashova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/5/332 |
Similar Items
-
Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson’s Disease
by: Petr G. Lokhov, et al.
Published: (2021-12-01) -
Metabolomic Laboratory-Developed Tests: Current Status and Perspectives
by: Steven Lichtenberg, et al.
Published: (2021-06-01) -
In Situ Mass Spectrometry Diagnostics of Impaired Glucose Tolerance using Label-Free Metabolomic Signature
by: Petr G. Lokhov, et al.
Published: (2020-12-01) -
Mass Spectrometry-Based Metabolomics Analysis of Obese Patients’ Blood Plasma
by: Petr G. Lokhov, et al.
Published: (2020-01-01) -
A Metabolomics Approach to Pharmacotherapy Personalization
by: Elena E. Balashova, et al.
Published: (2018-09-01)